guanethidine has been researched along with Eye Manifestations in 14 studies
Guanethidine: An antihypertensive agent that acts by inhibiting selectively transmission in post-ganglionic adrenergic nerves. It is believed to act mainly by preventing the release of norepinephrine at nerve endings and causes depletion of norepinephrine in peripheral sympathetic nerve terminals as well as in tissues.
guanethidine : A member of the class of guanidines in which one of the hydrogens of the amino group has been replaced by a 2-azocan-1-ylethyl group.
guanethidine sulfate : A organic sulfate salt composed of two molecules of guanethidine and one of sulfuric acid.
Eye Manifestations: Ocular disorders attendant upon non-ocular disease or injury.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Assessment was made of 5% local guanethidine in treating eye manifestations in euthyroid patients with either treated thyrotoxicosis or ophthalmic Graves's disease." | 5.03 | Critical study of 5 per cent guanethidine in ocular manifestations of Graves's disease. ( Anderson, J; Cartlidge, NE; Crombie, AL; Hall, R, 1969) |
| "Local application of guanethidine to the eye results in miosis." | 3.64 | GUANETHIDINE AND PUPILLARY REACTION. ( DORIAN, W; SCHIRMER, KE, 1964) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DORIAN, W | 1 |
| SCHIRMER, KE | 1 |
| Crombie, AL | 3 |
| Lawson, AA | 2 |
| Davis, PJ | 1 |
| Davis, FB | 1 |
| Sneddon, JM | 1 |
| Turner, P | 1 |
| Ivy, HK | 1 |
| Bowden, AN | 1 |
| Rose, FC | 1 |
| Cartlidge, NE | 1 |
| Anderson, J | 1 |
| Hall, R | 1 |
| Berkman, N | 1 |
| Joseph, E | 1 |
| Storch, J | 1 |
| Küchle, HJ | 1 |
| Cant, JS | 2 |
| Lewis, DR | 2 |
| Harrison, MT | 1 |
3 trials available for guanethidine and Eye Manifestations
| Article | Year |
|---|---|
Adrenergic blocking agents. A double-blind trial in the treatment of the eye signs of thyroid disorders.
Topics: Antihypertensive Agents; Bretylium Compounds; Clinical Trials as Topic; Edema; Exophthalmos; Eye Dis | 1968 |
Dysthyroid eye disease. A trial of guanethidine eye drops.
Topics: Clinical Trials as Topic; Eye Manifestations; Eyelids; Female; Graves Disease; Guanethidine; Humans; | 1969 |
Critical study of 5 per cent guanethidine in ocular manifestations of Graves's disease.
Topics: Clinical Trials as Topic; Eye Manifestations; Eyelid Diseases; Female; Graves Disease; Guanethidine; | 1969 |
11 other studies available for guanethidine and Eye Manifestations
| Article | Year |
|---|---|
GUANETHIDINE AND PUPILLARY REACTION.
Topics: Cocaine; Epinephrine; Eye Manifestations; Guanethidine; Horner Syndrome; Humans; Miosis; Mydriasis; | 1964 |
Long-term trial of local guanethidine in treatment of eye signs of thyroid dysfunction and idiopathic lid retraction.
Topics: Edema; Exophthalmos; Eye Manifestations; Eyelids; Female; Guanethidine; Humans; Hyperthyroidism; Hyp | 1967 |
Editorial: The eye signs of Graves disease.
Topics: Edema; Exophthalmos; Eye; Eye Manifestations; Female; Graves Disease; Guanethidine; Humans; Male; Mu | 1974 |
Hyperthyroidism in patients over the age of 60 years. Clinical features in 85 patients.
Topics: Age Factors; Aged; Arteriosclerosis; Blood Glucose; Blood Sedimentation; Body Weight; Calcium; Chole | 1974 |
Adrenergic blockade and the eye signs of thyrotoxicosis.
Topics: Eye Manifestations; Eyelids; Female; Guanethidine; Humans; Hyperthyroidism; Propranolol; Sympatholyt | 1966 |
Medical approach to ophthalmopathy of Graves' disease.
Topics: Adrenal Cortex Hormones; Adrenergic beta-Antagonists; Adrenocorticotropic Hormone; Diagnosis, Differ | 1972 |
[Ocular manifestations of Basedow's disease and local administration of guanethidine].
Topics: Eye Manifestations; Female; Graves Disease; Guanethidine; Humans; Male; Ophthalmic Solutions | 1971 |
[Action of 5 per cent guanethidine sulfate (ismeline) eye drops on lid retraction during Basedow's disease].
Topics: Adult; Eye Manifestations; Eyelid Diseases; Eyelids; Female; Graves Disease; Guanethidine; Humans; M | 1971 |
[Therapy of endocrine ophthalmopathies].
Topics: Adrenal Cortex Hormones; Endocrine System Diseases; Exophthalmos; Eye Manifestations; Eyelids; Guane | 1968 |
Treatment of dysthyroid ophthalmopathy with local guanethidine.
Topics: Eye Manifestations; Eyelids; Female; Graves Disease; Guanethidine; Humans; Hyperthyroidism; Male; Mi | 1969 |
Unwanted pharmacological effects of local guanethidine in the treatment of dysthyroid upper lid retraction.
Topics: Drug Hypersensitivity; Eye Manifestations; Eyelids; Female; Graves Disease; Guanethidine; Humans; Ke | 1969 |